Trial ID or NCT#

NCT00101933

Status

NOT RECRUITING

Purpose

The purpose of this research is to study the safety and effectiveness of bilateral stimulation of the anterior nucleus of the thalamus as adjunctive therapy for reducing the frequency of seizures in adults diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are refractory to antiepileptic medications.

Official Title

SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Robert Fisher, MD, PhD
Epilepsy specialist, Neurophysiologist
The Maslah Saul Professor in the Department of Neurology and Professor, by courtesy, of Neurosurgery at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Mimi Callanan, NP